A purified #inactivated #SARSCoV2 virus #vaccine candidate (#PiCoVacc) confers complete protection in #nonhuman primates against SARSCoV2 strains circulating worldwide by eliciting potent #humoral responses devoid of #immunopathology . https://t.co/2fvGnMn
RT @masahirono: サイエンス記事が参照していた中国の論文はこちらのほうかな。これはコロナの不活化ワクチン。論文ではコロナの株をVeroで10回継代し、b-propiolactoneでウイルス不活化、これをワクチンとして用いた サルを使った実験で中和抗体ならびに防御…
RT @masahirono: サイエンス記事が参照していた中国の論文はこちらのほうかな。これはコロナの不活化ワクチン。論文ではコロナの株をVeroで10回継代し、b-propiolactoneでウイルス不活化、これをワクチンとして用いた サルを使った実験で中和抗体ならびに防御…
RT @mzcandela: Amigos este es el primer dato preclínico 'serio' que he visto para un candidato a vacuna real. Esta es una vacuna inactivada…
RT @masahirono: サイエンス記事が参照していた中国の論文はこちらのほうかな。これはコロナの不活化ワクチン。論文ではコロナの株をVeroで10回継代し、b-propiolactoneでウイルス不活化、これをワクチンとして用いた サルを使った実験で中和抗体ならびに防御…
中国の研究チーム、新型コロナワクチンの動物実験結果を発表👍 https://t.co/K9iaIvoAb2 Rapid development of an inactivated vaccine for SARS-CoV-2 ←これかな😊 https://t.co/C7PNmdtYPO
RT @masahirono: サイエンス記事が参照していた中国の論文はこちらのほうかな。これはコロナの不活化ワクチン。論文ではコロナの株をVeroで10回継代し、b-propiolactoneでウイルス不活化、これをワクチンとして用いた サルを使った実験で中和抗体ならびに防御…
RT @masahirono: サイエンス記事が参照していた中国の論文はこちらのほうかな。これはコロナの不活化ワクチン。論文ではコロナの株をVeroで10回継代し、b-propiolactoneでウイルス不活化、これをワクチンとして用いた サルを使った実験で中和抗体ならびに防御…
RT @masahirono: サイエンス記事が参照していた中国の論文はこちらのほうかな。これはコロナの不活化ワクチン。論文ではコロナの株をVeroで10回継代し、b-propiolactoneでウイルス不活化、これをワクチンとして用いた サルを使った実験で中和抗体ならびに防御…
RT @masahirono: サイエンス記事が参照していた中国の論文はこちらのほうかな。これはコロナの不活化ワクチン。論文ではコロナの株をVeroで10回継代し、b-propiolactoneでウイルス不活化、これをワクチンとして用いた サルを使った実験で中和抗体ならびに防御…
RT @masahirono: サイエンス記事が参照していた中国の論文はこちらのほうかな。これはコロナの不活化ワクチン。論文ではコロナの株をVeroで10回継代し、b-propiolactoneでウイルス不活化、これをワクチンとして用いた サルを使った実験で中和抗体ならびに防御…
RT @masahirono: サイエンス記事が参照していた中国の論文はこちらのほうかな。これはコロナの不活化ワクチン。論文ではコロナの株をVeroで10回継代し、b-propiolactoneでウイルス不活化、これをワクチンとして用いた サルを使った実験で中和抗体ならびに防御…
RT @masahirono: サイエンス記事が参照していた中国の論文はこちらのほうかな。これはコロナの不活化ワクチン。論文ではコロナの株をVeroで10回継代し、b-propiolactoneでウイルス不活化、これをワクチンとして用いた サルを使った実験で中和抗体ならびに防御…
RT @masahirono: サイエンス記事が参照していた中国の論文はこちらのほうかな。これはコロナの不活化ワクチン。論文ではコロナの株をVeroで10回継代し、b-propiolactoneでウイルス不活化、これをワクチンとして用いた サルを使った実験で中和抗体ならびに防御…
RT @masahirono: サイエンス記事が参照していた中国の論文はこちらのほうかな。これはコロナの不活化ワクチン。論文ではコロナの株をVeroで10回継代し、b-propiolactoneでウイルス不活化、これをワクチンとして用いた サルを使った実験で中和抗体ならびに防御…
RT @masahirono: サイエンス記事が参照していた中国の論文はこちらのほうかな。これはコロナの不活化ワクチン。論文ではコロナの株をVeroで10回継代し、b-propiolactoneでウイルス不活化、これをワクチンとして用いた サルを使った実験で中和抗体ならびに防御…
RT @masahirono: サイエンス記事が参照していた中国の論文はこちらのほうかな。これはコロナの不活化ワクチン。論文ではコロナの株をVeroで10回継代し、b-propiolactoneでウイルス不活化、これをワクチンとして用いた サルを使った実験で中和抗体ならびに防御…
RT @masahirono: サイエンス記事が参照していた中国の論文はこちらのほうかな。これはコロナの不活化ワクチン。論文ではコロナの株をVeroで10回継代し、b-propiolactoneでウイルス不活化、これをワクチンとして用いた サルを使った実験で中和抗体ならびに防御…
RT @masahirono: サイエンス記事が参照していた中国の論文はこちらのほうかな。これはコロナの不活化ワクチン。論文ではコロナの株をVeroで10回継代し、b-propiolactoneでウイルス不活化、これをワクチンとして用いた サルを使った実験で中和抗体ならびに防御…
RT @masahirono: サイエンス記事が参照していた中国の論文はこちらのほうかな。これはコロナの不活化ワクチン。論文ではコロナの株をVeroで10回継代し、b-propiolactoneでウイルス不活化、これをワクチンとして用いた サルを使った実験で中和抗体ならびに防御…
RT @masahirono: サイエンス記事が参照していた中国の論文はこちらのほうかな。これはコロナの不活化ワクチン。論文ではコロナの株をVeroで10回継代し、b-propiolactoneでウイルス不活化、これをワクチンとして用いた サルを使った実験で中和抗体ならびに防御…
RT @masahirono: サイエンス記事が参照していた中国の論文はこちらのほうかな。これはコロナの不活化ワクチン。論文ではコロナの株をVeroで10回継代し、b-propiolactoneでウイルス不活化、これをワクチンとして用いた サルを使った実験で中和抗体ならびに防御…
サイエンス記事が参照していた中国の論文はこちらのほうかな。これはコロナの不活化ワクチン。論文ではコロナの株をVeroで10回継代し、b-propiolactoneでウイルス不活化、これをワクチンとして用いた サルを使った実験で中和抗体ならびに防御免疫を誘導したという https://t.co/e5wo8Y2hyj
RT @florian_krammer: 1) So, this is the first 'serious' preclinical data I have seen for an actual vaccine candidate. This one is an inacti…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @StearnsLab: Now out in Science: https://t.co/dDf58lOEjm
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: Encouraging news for #COVID19 vaccines: preprint shows inactivated #SARSCoV2 virus injected into rodents & monkeys induces n…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @NICU_doc_salone: The excitement at starting to see covid vaccines working in animal models https://t.co/bkMeZutwan
The excitement at starting to see covid vaccines working in animal models https://t.co/bkMeZutwan
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
Amigos este es el primer dato preclínico 'serio' que he visto para un candidato a vacuna real. Esta es una vacuna inactivada de SARS-CoV-2 hecha por Sinovac y parece trabajar en NHP https://t.co/2DK6gPBP8t
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
A paper has just been published which demonstrates how, using one of the "classic" approaches in the vaccination encouraging results have been obtained in animal trials. https://t.co/vbhW0Ms9C1 https://t.co/vJ9k0pMwLZ
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: Encouraging news for #COVID19 vaccines: preprint shows inactivated #SARSCoV2 virus injected into rodents & monkeys induces n…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @PeterHotez: I enjoy reading about "old school" vaccines like this inactivated virus #COVID19 #vaccine out of #China, it's looking like…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @PeterHotez: I enjoy reading about "old school" vaccines like this inactivated virus #COVID19 #vaccine out of #China, it's looking like…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…
RT @davidrliu: The inactivated #COVID19 #SARSCoV2 vaccine study is now published (submitted April 10, accepted May 2, published May 6—well…